Morbihan Disease: A Diagnostic and Therapeutic Challenge
DOI:
https://doi.org/10.20344/amp.19904Keywords:
Doxycycline, Facial Dermatoses, RosaceaAbstract
N/a.
Downloads
References
Donthi D, Nenow J, Samia A, Phillips C, Papalas J, Prenshaw K. Morbihan disease: a diagnostic dilemma: two cases with successful resolution. SAGE Open Med Case Rep. 2021;9:2050313X211023655. DOI: https://doi.org/10.1177/2050313X211023655
Smith LA, Cohen DE. Successful long-term use of oral isotretinoin for the management of morbihan disease: a case series report and review of the literature. Arch Dermatol. 2012;148:1395-8. DOI: https://doi.org/10.1001/archdermatol.2012.3109
Veraldi S, Persico M, Francia C. Morbihan syndrome. Indian Dermatol Online J. 2013;4:122. DOI: https://doi.org/10.4103/2229-5178.110639
Fujimoto N, Mitsuru M, Tanaka T. Successful treatment of morbihan disease with long-term minocycline and its association with mast cell infiltration. Acta Derm Venereol. 2015;95:368-9. DOI: https://doi.org/10.2340/00015555-1954
Boparai RS, Levin AM, Lelli GJ. Morbihan disease treatment: two case reports and a systematic literature review. Ophthalmic Plast Reconstr Surg. 2019;35:126-32. DOI: https://doi.org/10.1097/IOP.0000000000001229
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
